Search results
5 Reasons Vertex Pharmaceuticals Is a Screaming Buy on the Dip
Motley Fool via Yahoo Finance· 7 hours agoAlpine acquisition In addition to developing new drug candidates internally, Vertex's CF profits...
AstraZeneca: What are the rare side effects of the Covid jab?
The Independent via Yahoo News· 6 hours agoThe vaccine, initially known as Covishield, was developed by thepharmaceutical giant in...
Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings
Barrons.com· 3 hours agoSTOCKSTOWATCHTODAY BLOG Shares of Teva Pharmaceutical Industries were climbing yet again on...
Minghui Pharmaceutical to Present the Phase I/II Study of MHB088C (B7-H3 ADC) for the Treatment of...
WTNH-TV New Haven· 6 hours agoMinghui Pharmaceutical, Inc., a late-stage clinical biopharmaceutical company focused on autoimmune...
Hong Kong attracts US$832 million in investment from life-science firms
South China Morning Post· 5 hours agoAmong the 45 companies, more than 60 per cent are in the therapeutics sector, which includes ...
Avadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...
GuruFocus.com via Yahoo Finance· 4 hours agoMay 8, 2024, Avadel Pharmaceuticals PLC (NASDAQ:AVDL) released its 8-K filing, announcing its...
NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual...
Digital Journal· 3 hours agoHARRISON TOWNSHIP, MI / ACCESSWIRE / May 8, 2024 / NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) is a clinical-stage biopharmaceutical company developing therapeutics ...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters via Yahoo Finance· 5 hours agoTeva Pharmaceutical Industries said it was set to launch its long awaited biosimilar of AbbVie's...
Teva Pharm Q1 profit misses estimates, revenue risea
WSAU Wausau· 2 hours agoBy Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets ...
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 4 hours agoMarinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 0% and 10.81%,...